Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies.

@article{Wolf2008ChemotherapyinducedPN,
  title={Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies.},
  author={Sherry L. Wolf and Debra L. Barton and Lisa A. Kottschade and Axel F Grothey and Charles M Loprinzi},
  journal={European journal of cancer},
  year={2008},
  volume={44 11},
  pages={1507-15}
}
Chemotherapy-induced peripheral neuropathy (CIPN) is a major dose limiting side effect of many commonly used chemotherapeutic agents, including platinum drugs, taxanes, epothilones and vinca alkaloids, and also newer agents such as bortezomib and lenolidamide. Symptom control studies have been conducted looking at ways to prevent or alleviate established CIPN. This manuscript provides a review of studies directed at both of these areas. New evidence strongly suggests that intravenous calcium… CONTINUE READING
181 Citations
69 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 181 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 69 references

Vitamin E in the neuroprotection of cisplatin induced peripheral neurotoxicity and ototoxicity

  • A Pace, S Carpano, E Galiè
  • Journal of Clinical Oncology
  • 2007
Highly Influential
10 Excerpts

A phase III randomized, placebo-controlled, double-blind study of intravenous calcium/magnesium to prevent oxaliplatininduced sensory neurotoxicity, N04C7

  • DA Nikcevich, A Grothey, JA Sloan
  • Journal of Clinical Oncology,
  • 2008
1 Excerpt

Effect of intravenous (IV) calcium and magnesium (Ca/Mg) versus placebo on response to FOLFOX+bevacizumab (BEV) in the CONcePT trial

  • HS Hochster, A Grothey, A Shpilsky, BH. Childs
  • Journal of Clinical Oncology,
  • 2008
1 Excerpt

Similar Papers

Loading similar papers…